Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of phantom stock units through the company's Supplemental Savings Plan.

Summary

• On August 15, 2024, Albert Bourla, Chairman & CEO of Pfizer Inc., acquired 18 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of common stock.
• The price of the common stock was $28.71.
• Following the transaction, Bourla directly owns 678,992 shares of common stock.
• The phantom stock units are settled in cash upon separation from service and can be transferred into an alternative investment account at any time.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.

Positives

• The acquisition of phantom stock units by the CEO demonstrates his continued investment in the company's future.

Industry Context

This filing is a routine disclosure of insider transactions, which are common among executives of publicly traded companies. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their executives.
• The Pfizer Supplemental Savings Plan is a common type of deferred compensation plan offered by many large corporations.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates